Phase 2 Study of First-line Intensity Modulated Radiation Therapy Followed by Gemcitabine, Dexamethasone, and Cisplatin for High-Risk, Early Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: The GREEN Study
2018 ◽
Vol 102
(1)
◽
pp. 61-70
◽
Keyword(s):
Phase 2
◽
2013 ◽
Vol 87
(2)
◽
pp. S364
2017 ◽
Vol 99
(2)
◽
pp. S178
2018 ◽
Vol 102
(3)
◽
pp. e358-e359
2015 ◽
Vol 93
(3)
◽
pp. S8
2017 ◽
Vol 96
(9)
◽
pp. 1477-1483
◽
2016 ◽
Vol 96
(2)
◽
pp. S49-S50
◽
2014 ◽
Vol 90
(1)
◽
pp. S529-S530
◽
2017 ◽
Vol 98
(5)
◽
pp. 1096-1105
◽
2013 ◽
Vol 87
(5)
◽
pp. 1086-1093
◽